144 related articles for article (PubMed ID: 26722501)
21. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
Geyh S; Oz S; Cadeddu RP; Fröbel J; Brückner B; Kündgen A; Fenk R; Bruns I; Zilkens C; Hermsen D; Gattermann N; Kobbe G; Germing U; Lyko F; Haas R; Schroeder T
Leukemia; 2013 Sep; 27(9):1841-51. PubMed ID: 23797473
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.
Lecourt S; Vanneaux V; Leblanc T; Leroux G; Ternaux B; Benbunan M; Chomienne C; Baruchel A; Marolleau JP; Gluckman E; Socié G; Soulier J; Larghero J
Stem Cells Dev; 2010 Feb; 19(2):203-8. PubMed ID: 19572808
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation.
Zhao S; Zhao Y; Guo J; Fei C; Zheng Q; Li X; Chang C
Sci Rep; 2017 Mar; 7():43849. PubMed ID: 28262842
[TBL] [Abstract][Full Text] [Related]
25. Impairment in immuno-modulatory function of Flk1(+)CD31(-)CD34(-) MSCs from MDS-RA patients.
Han Q; Sun Z; Liu L; Chen B; Cao Y; Li K; Zhao RC
Leuk Res; 2007 Nov; 31(11):1469-78. PubMed ID: 17360037
[TBL] [Abstract][Full Text] [Related]
26. [Senescent Mesenchymal Stem Cells Contribute to Progression of Myelodysplastic Syndromes-Review].
Pang YB; Li WW; Luo JM; Ji J; DU X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):942-946. PubMed ID: 29950248
[TBL] [Abstract][Full Text] [Related]
27. [Expression of SDF-1 gene in bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome].
Zhang YZ; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):281-4. PubMed ID: 16638197
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.
Sarhan D; Wang J; Sunil Arvindam U; Hallstrom C; Verneris MR; Grzywacz B; Warlick E; Blazar BR; Miller JS
JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32045384
[TBL] [Abstract][Full Text] [Related]
29. Influence of in vitro biomimicked stem cell 'niche' for regulation of proliferation and differentiation of human bone marrow-derived mesenchymal stem cells to myocardial phenotypes: serum starvation without aid of chemical agents and prevention of spontaneous stem cell transformation enhanced by the matrix environment.
Kim JH; Shin SH; Li TZ; Suh H
J Tissue Eng Regen Med; 2016 Jan; 10(1):E1-13. PubMed ID: 23897724
[TBL] [Abstract][Full Text] [Related]
30. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
[TBL] [Abstract][Full Text] [Related]
31. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
[TBL] [Abstract][Full Text] [Related]
32. [Immuno-suppressive effects on T cells mediated by mesenchymal stem cells from patients with myelodysplastic syndrome].
Liu LH; Chen H; Chen B; Sun Z; Ye LP; Shi B; Jin JG; Zhao CH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):299-304. PubMed ID: 18426653
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of Mesenchymal Stromal Cells in Myelodysplastic Syndrome-with Multilineage Dysplasia (MDS-MLD).
Abbas S; Kumar S; Srivastava VM; Therese M M; Nair SC; Abraham A; Mathews V; George B; Srivastava A
Indian J Hematol Blood Transfus; 2019 Apr; 35(2):223-232. PubMed ID: 30988556
[TBL] [Abstract][Full Text] [Related]
34. [In vitro biological characteristics of mesenchymal stem cells from patients with myelodysplastic syndrome and their support to hematopoiesis].
Zhang YZ; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):839-42. PubMed ID: 16277854
[TBL] [Abstract][Full Text] [Related]
35. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
[TBL] [Abstract][Full Text] [Related]
36. p16(INK4A) mediates age-related changes in mesenchymal stem cells derived from human dental pulp through the DNA damage and stress response.
Feng X; Xing J; Feng G; Huang D; Lu X; Liu S; Tan W; Li L; Gu Z
Mech Ageing Dev; 2014; 141-142():46-55. PubMed ID: 25304494
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.
Mantelli M; Avanzini MA; Rosti V; Ingo DM; Conforti A; Novara F; Arrigo G; Boni M; Zappatore R; Lenta E; Moretta A; Acquafredda G; de Silvestri A; Cirillo V; Cicchetti E; Algeri M; Strocchio L; Vinti L; Starc N; Biagini S; Sirleto P; Bernasconi P; Zuffardi O; Maserati E; Maccario R; Zecca M; Locatelli F; Bernardo ME
Br J Haematol; 2015 Sep; 170(6):826-36. PubMed ID: 26010568
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival.
Johnson RC; Kurzer JH; Greenberg PL; Gratzinger D
Am J Clin Pathol; 2014 Dec; 142(6):795-802. PubMed ID: 25389333
[TBL] [Abstract][Full Text] [Related]
39. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
[TBL] [Abstract][Full Text] [Related]
40. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
